Cargando…

Comparative Safety and Effectiveness of Oral Anticoagulants in Nonvalvular Atrial Fibrillation: The NAXOS Study

BACKGROUND AND PURPOSE: The effects of direct oral anticoagulants in nonvalvular atrial fibrillation should be assessed in actual conditions of use. France has near-universal healthcare coverage with a unified healthcare information system, allowing large population-based analyses. NAXOS (Evaluation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Van Ganse, Eric, Danchin, Nicolas, Mahé, Isabelle, Hanon, Olivier, Jacoud, Flore, Nolin, Maëva, Dalon, Faustine, Lefevre, Cinira, Cotté, François-Emery, Gollety, Sabrina, Falissard, Bruno, Belhassen, Manon, Steg, Ph. Gabriel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2020
Materias:	Original Contributions
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306262/ https://www.ncbi.nlm.nih.gov/pubmed/32539675 http://dx.doi.org/10.1161/STROKEAHA.120.028825

Ejemplares similares

Apixaban versus other anticoagulants in patients with nonvalvular fibrillation: a comparison of all-cause and event-related costs in real-life setting in France
por: Belhassen, Manon, et al.
Publicado: (2022)

EvaluatioN of ApiXaban in strOke and systemic embolism prevention in patients with non‐valvular atrial fibrillation in clinical practice Setting in France, rationale and design of the NAXOS: SNIIRAM study
por: Picard, Fabien, et al.
Publicado: (2019)

Comparative outcomes in patients receiving pirfenidone or nintedanib for idiopathic pulmonary fibrosis
por: Belhassen, Manon, et al.
Publicado: (2021)

Trajectories of Controller Therapy Use Before and After Asthma-Related Hospitalization in Children and Adults: Population-Based Retrospective Cohort Study
por: Belhassen, Manon, et al.
Publicado: (2023)

Impact of Therapy Persistence on Exacerbations and Resource Use in Patients Who Initiated COPD Therapy
por: Dalon, Faustine, et al.
Publicado: (2019)

Dual versus triple therapy in patients hospitalized for COPD in France: a claims data study
por: Dalon, Faustine, et al.
Publicado: (2019)

Mortality and Respiratory-Related Hospitalizations in Idiopathic Pulmonary Fibrosis Not Treated With Antifibrotics
por: Cottin, Vincent, et al.
Publicado: (2021)

Cancer incidence and prevalence in cystic fibrosis patients with and without a lung transplant in France
por: Rousset-Jablonski, Christine, et al.
Publicado: (2022)

Antipsychotic prescribing practices in real-life (APPREAL study): Findings from the French National Healthcare System Database (2007–2017)
por: Rolland, Benjamin, et al.
Publicado: (2022)

Differences in severe exacerbations rates and healthcare utilisation in COPD populations in the UK and France
por: Whittaker, Hannah, et al.
Publicado: (2022)

Treatment of Allergic Rhinitis and Asthma in Primary Care: Dispensations Do Not Align with Prescriptions
por: Belhassen, Manon, et al.
Publicado: (2022)

Naxos Disease
por: Protonotarios, Nikos, et al.
Publicado: (2005)

Ariadne auf Naxos
por: Strauss, Richard, 1864-1949
Publicado: (1988)

Naxos Disease in Two Siblings
por: Meera, G, et al.
Publicado: (2010)

Naxos disease: from the origin to today
por: Li, Guo-Liang, et al.
Publicado: (2018)

Naxos Disease: The Model for Scientific Discovery
por: Yesudian, Rohan, et al.
Publicado: (2020)

Cocooning strategy: Pertussis vaccination coverage rate of parents with a new-born in 2016 and 2017 in France
por: Marchal, Clarisse, et al.
Publicado: (2022)

Naxos disease: Cardiocutaneous syndrome due to cell adhesion defect
por: Protonotarios, Nikos, et al.
Publicado: (2006)

Living after sudden death: A case report of Naxos disease
por: Noain, Jose Alberto Garcia, et al.
Publicado: (2012)

Carvajal Syndrome- A Variant of Naxos Disease: A Case Report
por: Mandal, Krishna Deo, et al.
Publicado: (2022)

Risk of Recurrent Bleeding Events in Nonvalvular Atrial Fibrillation Treated with Vitamin K Antagonists: A Clinical Practice Research Datalink Study
por: Alikhan, Raza, et al.
Publicado: (2019)

Proceedings of the Topical Workshop on Electronics for Particle Physics: Naxos, Greece 15 - 19 Sep 2008
por: Dho, Evelyne, et al.
Publicado: (2008)

The lateral boundary of a metamorphic core complex: The Moutsounas shear zone on Naxos, Cyclades, Greece()
por: Cao, Shuyun, et al.
Publicado: (2013)

Earliest occupation of the Central Aegean (Naxos), Greece: Implications for hominin and Homo sapiens’ behavior and dispersals
por: Carter, Tristan, et al.
Publicado: (2019)

Physician's Fear of Anticoagulant Therapy in Nonvalvular Atrial Fibrillation
por: Sen, Souvik, et al.
Publicado: (2014)

Different clinical presentations of Naxos disease and Carvajal syndrome: Case series from a single tertiary center and review of the literature
por: Baykan, Ali, et al.
Publicado: (2015)

Variant NAXOS-Carvajal Syndrome with Rare Additional Features of Systemic Bulla and Brittle Nails: A Case Report and Literature Review
por: Sato, Takanori, et al.
Publicado: (2020)

Underuse of oral anticoagulants in patients with nonvalvular atrial fibrillation in Italy
por: Ferro, D., et al.
Publicado: (2007)

Direct Oral Anticoagulants in Patients With Cancer and Nonvalvular Atrial Fibrillation
por: Davis, Margot K., et al.
Publicado: (2021)

Prescribed therapy for asthma: therapeutic ratios and outcomes
por: Laforest, Laurent, et al.
Publicado: (2015)

Erratum to: Prescribed therapy for asthma: therapeutic ratios and outcomes
por: Laforest, Laurent, et al.
Publicado: (2016)

Laboratory Assessment of the Anticoagulant Activity of Apixaban in Patients With Nonvalvular Atrial Fibrillation
por: Kyriakou, Elias, et al.
Publicado: (2018)

Anticoagulants in Older Patients with Nonvalvular Atrial Fibrillation after Intracranial Hemorrhage
por: Perreault, Sylvie, et al.
Publicado: (2019)

Cost Implications of Formulary Decisions on Oral Anticoagulants in Nonvalvular Atrial Fibrillation
por: Biskupiak, Joseph, et al.
Publicado: (2013)

How to choose appropriate direct oral anticoagulant for patient with nonvalvular atrial fibrillation
por: Schaefer, Jordan K., et al.
Publicado: (2015)

Factors Associated with Ischemic Stroke on Therapeutic Anticoagulation in Patients with Nonvalvular Atrial Fibrillation
por: Kim, Young Dae, et al.
Publicado: (2015)

The use status of anticoagulation drugs for inpatients with nonvalvular atrial fibrillation in Southwest China
por: Zheng, Huan Jie, et al.
Publicado: (2017)

Comparisons between Oral Anticoagulants among Older Nonvalvular Atrial Fibrillation Patients
por: Deitelzweig, Steven, et al.
Publicado: (2019)

Current Anticoagulant Usage Patterns and Determinants in Korean Patients with Nonvalvular Atrial Fibrillation
por: Ha, Hyun Su, et al.
Publicado: (2020)

Oral Anticoagulants for Nonvalvular Atrial Fibrillation in Patients With High Risk of Gastrointestinal Bleeding
por: Lip, Gregory Y. H., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_duf8klr6sug5kjdc3lrcb65irr